⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25387200 | 1.00 | — | — | |
| SCHEMBL25387203 | 1.00 | — | — | |
| SCHEMBL25385854 | 0.81 | — | — | |
| SCHEMBL25385850 | 0.81 | — | — | |
| SCHEMBL25385856 | 0.81 | — | — | |
| SCHEMBL31065364 | 0.73 | CA2 (0.31) | — | |
| SCHEMBL10920720 | 0.73 | CA2 (0.31) | — | |
| SCHEMBL11027021 | 0.73 | CA2 (0.31) | — | |
| SCHEMBL14156537 | 0.71 | — | — | |
| SCHEMBL14213017 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4486753-B1 | BROAD SPECTRUM AMINOGLYCOSIDES AND USES THEREOF | REVAGENIX INC (US) | 2026-05-13 | — | — | EP | disclosed |
| US-20250032524-A1 | BROAD SPECTRUM AMINOGLYCOSIDES AND USES THEREOF | REVAGENIX INC (US) | 2025-01-30 | — | — | US | disclosed |
| EP-4486753-A1 | BROAD SPECTRUM AMINOGLYCOSIDES AND USES THEREOF | Revagenix, Inc. (US) | 2025-01-08 | — | — | EP | disclosed |
| WO-2023166488-A1 | BROAD SPECTRUM AMINOGLYCOSIDES AND USES THEREOF | REVAGENIX, INC. (US) | 2023-09-07 | — | — | WO | disclosed |